These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 21039318)

  • 21. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmucosal macromolecular drug delivery.
    Prego C; García M; Torres D; Alonso MJ
    J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiolated chitosans: useful excipients for oral drug delivery.
    Werle M; Bernkop-Schnürch A
    J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
    Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
    Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B; Xing Y; Zheng Y; Sun C; Liang G
    Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
    Krauland AH; Leitner VM; Grabovac V; Bernkop-Schnürch A
    J Pharm Sci; 2006 Nov; 95(11):2463-72. PubMed ID: 16886206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
    Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
    Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
    Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro evaluation of a novel thiolated chitosan.
    Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
    Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack.
    Martien R; Loretz B; Schnürch AB
    Biopolymers; 2006 Nov; 83(4):327-36. PubMed ID: 16609969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
    Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
    Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
    Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.